rhoGDIs (Rho GDP dissociation inhibitors) are postulated to regulate the activity and the localization of small G-proteins of the Rho family by a shuttling process involving extraction of Rho from donor membranes, formation of inhibitory cytosolic rhoGDI/Rho complexes, and delivery of Rho to target membranes. However, the role of rhoGDIs in site-specific membrane targeting or extraction of Rho is still poorly understood. We investigated here the in vivo functions of two mammalian rhoGDIs: the specific rhoGDI-3 and the wellstudied rhoGDI-1 (rhoGDI) after structure-based mutagenesis. We identified two sites in rhoGDIs, forming conserved interactions with their Rho target, whose mutation results in the uncoupling of inhibitory and shuttling functions of rhoGDIs in vivo. Remarkably, these rhoGDI mutants were detected at Rho-induced membrane ruffles or protrusions, where they co-localized with RhoG or Cdc42, probably identifying for the first time the site of extraction of a Rho protein by a rhoGDI in vivo. We propose that these mutations act by modifying the steady-state kinetics of the shuttling process regulated by rhoGDIs, such that transient steps at the cell membranes now become detectable. They should provide valuable tools for future investigations of the dynamics of membrane extraction or delivery of Rho proteins and their regulation by cellular partners.
Introduction
Small G-proteins of the Rho family regulate many features of the normal cell such as polarity, motility, vesicular traffic and cell-cycle progression [1] [2] [3] . They are moreover involved in Ras-mediated transformation, and progression and metastasis of malignant tumours, thus showing the importance of a well-balanced regulation of the Rho proteins [4] . These proteins function as molecular switches by cycling between an inactive GDP-bond form and an active GTPbond form capable of interacting with effectors. This cycle is coupled with a cytosol/membrane alternation. While the GDP/GTP cycle is controlled by GEFs (guanine nucleotideexchange factors) and GAPs (GTPase-activating proteins), the cytosol/membrane shuttling process of Rho proteins is ensured by rhoGDIs (Rho GDP dissociation inhibitors). RhoGDIs regulate the cytosol/membrane partition of the Rho proteins by extracting them from biological membranes and keeping them in their inactive GDP-bound form in the cytoplasm. Whether rhoGDIs act in this process only as subsidiary transporters of inactivated Rho proteins or as essential participants in Rho activity is currently debated.
Moreover, in order to ensure the specificity of the Rhoinduced signal, regulation of Rho proteins is finely tuned and requires a strict spatiotemporal co-ordination of several regulators (GEF, GAP and GDI) and specific effectors.
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In particular, the molecular mechanisms that lead to the dissociation of the rhoGDI/Rho complex and the consecutive activation of Rho by GEF are still unclear, despite numerous investigations on this topic. Resolution of X-ray structures [5] of several rhoGDI/Rho complexes provides important information on the functional interfaces between the two proteins. They also underline the presence of two structural modules of the rhoGDI molecule, an N-terminal flexible arm and a C-terminal Ig-like domain (Figure 1 ), whose relative movements could be crucial for its function. Indeed, this suggested that flexibility could play an important role during some more unusual activities of rhoGDIs, which are not yet quite understood. In order to better understand the structure/function relationships of rhoGDIs, we report here a structure-based mutagenesis study of rhoGDIs, taking advantages of an unconventional biological system constituted by rhoGDI-3 and its specific binding partner, RhoG.
Uncoupling of inhibitory and shuttling functions of rhoGDIs
Difficulties in investigating rhoGDI functions in vivo come from the lack of specificity of rhoGDI-1 and LyGDI, two of the three rhoGDIs identified as yet. Indeed rhoGDI-1 (referred to as GDI-1 hereafter) can regulate a wide range of Rho proteins, and the in vivo partners of LyGDI are not well known. However, a third rhoGDI identified by us, rhoGDI-3 [6] (referred to as GDI-3 hereafter), was shown to regulate specifically the shuttling process of the small Shown is a model of the RhoG-GDI-3 complex. RhoG is in grey with switch 1 in mauve and switch 2 in orange and GDI-3 is in blue. Regions of GDI-3, which carry the mutations, are in green and the exact mutated amino acid position is also indicated in green. The mutant GDI-3 D66A results from the mutations of Asp 66 to Ala. The mutant GDI-3 D66A/S68I was designed to add a steric hindrance to the D66A (Asp 66 → Ala) mutation, by modifying the proximal Ser 68 to Ile. Asp 206 was mutated to either Ala or to Ile to obtain the GDI-3 D206A and GDI-3 D206I mutants respectively. Finally, each of the residues from the tandem Arg 159 /Lys 162 was mutated into Ala to obtain the mutant GDI-3 R159A/K162A , also called GDI-3 DM . Nt, N-terminus; Ct, C-terminus; SI, switch 1; SII, switch 2.
G-protein RhoG [7] . Moreover, it possesses an N-terminal extension of 25 residues, absent from other rhoGDIs, which targets rhoGDI-3 specifically to the Golgi apparatus. When transiently expressed in HeLa cells, RhoG is localized to the Golgi, the endoplasmic reticulum, and in plasma membrane protrusions named lamellipodia, which are hallmarks of its activation ( Figure 2A, bottom panel) . Co-expression with GDI-3 induces a relocalization of RhoG from the plasma membrane to the Golgi apparatus and the cytoplasm, with a concomitant disappearance of lamellipodia, indicating the inhibition of RhoG activity by GDI-3 (see Figure 2B , lower panel). We took advantages of this high specificity and unique readout of the GDI-3-RhoG system to investigate the effects of GDI-3 mutations in vivo [8] .
After analysis of the modelled GDI-3-RhoG complex structure, residues to mutate were chosen among amino acids conserved in all rhoGDIs and involved in crucial interfaces between the two proteins ( Figure 1 Ala or Ile. The localization and nature of the mutations are detailed in Figure 1 . Effects of these mutations on the ability of GDI-3 mutants to inhibit RhoG were assessed by immunofluorescence in HeLa cells, by analysing the level of RhoG activation that is defined here by the appearance of RhoG-induced lamellipodia and the relocalization of RhoG to these membrane structures. GDI-3 mutants were also tested for their capacity to bind to RhoG, by co-immunoprecipitation and yeast two-hybrid assays. As reported previously, when coexpressed with GDI-3wt, RhoG does not induce membrane ruffles. It is no longer detected at the cell periphery and it accumulates on the Golgi cisternae where it co-localizes with GDI-3 ( Figure 2B ). A similar phenotype was observed for the mutant GDI-3 DM , which is probably behaving similarly to GDI-3wt (results not shown). In contrast, GDI-3 proteins mutated at the 66 or 206 amino acid positions did not inhibit RhoG-induced cell morphology. Hence, RhoG was not only detected around the nucleus and the Golgi apparatus, but also found with a punctuate distribution throughout the cytoplasm and in RhoG-induced membrane ruffles (Figure 2C , lower panel), as observed in cells expressing RhoG alone (Figure 2A, lower panel) . The finding that RhoG was able to get activated and translocate to the cell periphery in the presence of these mutants indicates that they are defective in their inhibitory activity.
The most striking phenomenon is that these GDI-3 mutants co-localize with RhoG at peripheral membrane ruffles (arrows in Figure 2C ). However, when expressed alone (Figure 2A , middle panel), these mutants do not have this remarkable localization, suggesting that it is strictly contingent on the presence of RhoG in these cells. Since RhoG and Asp 66 /Asp 206 mutants of GDI-3 concomitantly localized at the cell periphery, we expected that the two proteins were still able to form cytosoluble complexes. Immunoprecipitation experiments ( Figure 2D ) carried out on cytosols from cotransfected HeLa cells demonstrate that these mutants indeed form cytosoluble complexes with RhoG, without significantly modifying the apparent stability of the complex compared with wild-type complexes. Interestingly, yeast twohybrid assays do not reveal any interaction between Asp 66 or Asp 206 GDI-3 mutants and RhoG, while GDI-3wt and GDI-3 DM interact in this system. These results suggest that mutation of residues Asp 66 or Asp 206 probably subtly modifies the GDI-3/RhoG complex, without inducing disruption of the complex in vivo.
In view of the above results with GDI-3, mutations of residues equivalent to Asp-66 GDI−3 (Asp-45 GDI−1 ) and Asp-206 (Asp-185 GDI−1 ) were introduced in the less-specific GDI-1 regulator and analysed for their effect on Cdc42 protein. Briefly, as found for the GDI-3 mutants, the corresponding GDI-1 mutants did not inhibit Cdc42 activation and Cdc42 was found localized not only to the perinuclear region, but also at the cell periphery in membrane protrusions called microspikes, which is the hallmark of its activation [9] . These GDI-1 mutants were also localized with the co-expressed Cdc42 to the cell periphery. In the same way, coimmunoprecipitations on HeLa cytosolic fractions revealed a conserved ability of these mutants to bind to Cdc42, while yeast two-hybrid assays suggested subtle modifications of the GDI-1-Cdc42 complex leading to its disruption in this system.
To conclude, we have identified two sites in rhoGDI proteins, namely Asp-66 GDI−3 (Asp-45 GDI−1 ) and Asp-206
(Asp-185 GDI−1 ), which form conserved interactions with their Rho target and whose mutations result in the uncoupling of inhibitory and shuttling functions of rhoGDIs.
GDI-3: a new biological system to investigate rhoGDI functions
The ability of GDI-3 mutants to bind RhoG, without inhibiting RhoG-induced lamellipodium formation, suggest that mutations of amino acids Asp 66 or Asp 206 probably induce subtle structural modifications of the GDI-3-RhoG complex. This could consist in an increased flexibility of GDI-3 structure allowing it either to accommodate an active GTPbond form of RhoG in the complex, or to induce a new GDPbond conformation compatible with interaction of RhoG with its effectors. This is compatible with results showing the necessity of rhoGDI-1-Rac1 complex formation in order to achieve Rac-dependent NADPH oxidase activation [10] . Indeed, these results argue in favour of a possible positive role of Rho-rhoGDI complexes in the transduction of some Rho-dependent signals to effectors, suggesting that rhoGDIs do not only act as auxiliary transporters of inactivated Rho proteins. The GDI-3-RhoG system could thus be a valuable tool in particular to understand better the biological relevance for the ability of rhoGDIs to bind to the GTP-bound form of Rho proteins in vitro [11] .
The remarkable co-localization of Asp 66 and Asp 206 GDI-3 mutants with RhoG at the cell periphery suggests that these mutations act by modifying the steady-state kinetics of the shuttling process of RhoG by GDI-3. We probably intercept here transient steps of this crucial process at the cell membrane, which are usually not observable in steadystate cells. These mutants could then provide valuable tools to investigate the dynamics of rhoGDIs in vivo. Indeed, the abundant literature on Rho proteins reveals that a given Rho protein can localize to distinct membrane compartments [12] where it probably activates distinct sets of effectors to ensure the specificity of the Rho-dependent signal. The role of rhoGDI in the determination of the proper membrane localization of Rho proteins is not known. Hence, the GDI-3-RhoG system could help to highlight as yet unexplored roles of rhoGDIs by allowing the in vivo study of their dynamics.
